Premier Integrated Labs spearheads a transformative partnership in Malaysia to tackle the rising burden of chronic kidney disease (CKD). With over five million affected Malaysians and low awareness rates, the collaboration aims to drive early detection and intervention using innovative digital tools.
PIL and Gene Solutions are partnering to advance cancer care with cutting-edge technology for early detection and monitoring, aiming for better patient outcomes.
Premier Integrated Labs (PIL) has been recognized as the Diagnostics Provider of the Year - Malaysia category at the recently held Healthcare Asia Awards 2024!
Thalassemia is a genetic blood disorder that affects the production of hemoglobin, the protein in red blood cells that carries oxygen. It can lead to anemia, fatigue, and other health problems if left untreated. Early detection is critical for better management and treatment of thalassemia, and our testing service can help healthcare providers identify patients with this condition.
Pantai Premier Pathology Gleneagles @ Kota Kinabalu has recently made history by becoming the first and only private medical laboratory in East Malaysia to receive the MS ISO 15189 accreditation. The accreditation is a testament to the lab's commitment to providing reliable and accurate medical testing services while adhering to high standards of performance, accountability and continuous improvement.
Pantai Premier Pathology Sdn. Bhd. extended its Memorandum of Understanding (MoU) with AFYAA Sdn. Bhd. The MoU initially signed on 21 November 2021, outlined the collaboration between both companies to encourage and educate the general public to do health assessments to prevent or treat illnesses in very early stages and to improve health by benefiting from the nutritional values of AFYAA's premium functional food products.
Pantai Premier Pathology's commitment to maintaining the highest quality standards and ensuring compliance with best practices in the industry was recently demonstrated through two successful workshops held in the first quarter of 2023 by the Quality, Standards & Accreditation Department.
Following the harmonisation of glucose reporting initiative by the Chapter of Chemical Pathology and Metabolic Medicine, College of Pathologists, Academy of Medicine of Malaysia and the Malaysian Endocrine and Metabolic Society (MEMS), kindly be informed that glucose reporting will now include prediabetes and diabetes reference intervals.
